Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Maria Nichols

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Immunobiology|January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patientsChristoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Antibodies (Basel, Switzerland)|October 26, 2021
Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex FormationLasse Stach, Emily K H Dinley, Nadia Tournier, et al.
Frontiers in Immunology|September 23, 2022
Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patientsEleonora Lekova, Wioleta M Zelek, David Gower, et al.
Science Immunology|April 8, 2021
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivationBingyu Yan, Tilo Freiwald, Daniel Chauss, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Immunobiology|January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patientsChristoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Antibodies (Basel, Switzerland)|October 26, 2021
Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex FormationLasse Stach, Emily K H Dinley, Nadia Tournier, et al.
Frontiers in Immunology|September 23, 2022
Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patientsEleonora Lekova, Wioleta M Zelek, David Gower, et al.
Science Immunology|April 8, 2021
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivationBingyu Yan, Tilo Freiwald, Daniel Chauss, et al.
Pageof 2